DALLAS--(BUSINESS WIRE)--EnLiSense is thrilled to announce the upcoming release of Corti this summer, their innovative wearable that is set to transform health tracking by offering personalized, proactive, and precise monitoring of the key stress and sleep hormones, Cortisol and Melatonin. The wearable features its proprietary passive-sweat sensor technology that non-invasively rests on your skin, day and night, continuously measuring biomarker levels.

达拉斯--（商业新闻短讯）--EnLiSense很高兴宣布Corti将于今年夏天发布，他们的创新可穿戴设备将通过提供个性化，主动和精确的关键压力和睡眠激素，皮质醇和褪黑激素监测来改变健康跟踪。可穿戴设备拥有专有的被动汗液传感器技术，日夜无创地躺在皮肤上，不断测量生物标志物水平。

Corti originated as a tool for identifying inflammation markers in autoimmune disorders. Now, it provides users with unmatched real-time insights into their wellness, establishing a new benchmark for the continuous monitoring of these critical biomarkers..

Corti起源于鉴定自身免疫性疾病中炎症标志物的工具。现在，它为用户提供了无与伦比的实时健康见解，为连续监测这些关键生物标志物建立了新的基准。。

Corti redefines health monitoring by offering continuous, real-time visibility into the body's key stress and sleep hormones, Cortisol and Melatonin, marking a first in the wearable market. These hormones undergo substantial fluctuations throughout the day, influenced by personal lifestyle choices. In fact, melatonin's activity levels change within just 20 to 30 minutes, and cortisol levels typically peak 15-30 minutes after stress onset, each while influenced by their unique circadian pattern illustrating the complex daily journey of our hormones.

Corti通过提供对身体关键压力和睡眠激素、皮质醇和褪黑激素的连续实时可视性，重新定义了健康监测，这在可穿戴设备市场上尚属首次。受个人生活方式选择的影响，这些激素在一天中会发生大幅波动。事实上，褪黑激素的活性水平仅在20到30分钟内发生变化，皮质醇水平通常在压力发作后15-30分钟达到峰值，而每种皮质醇水平都受到其独特的昼夜节律模式的影响，这说明了我们激素的复杂日常旅程。

Unlike traditional hormone assessments that often yield a single, less informative snapshot, Corti delivers an unparalleled depth of data, capturing more than 3,000 measurements for each biomarker in a single week. This extensive data allows users to observe both the immediate and long-term effects their lifestyle decisions have on their health, providing a detailed view of their hormone levels' natural circadian rhythms for the first time..

与传统的激素评估通常产生单一的，信息量较小的快照不同，Corti提供了无与伦比的数据深度，在一周内为每个生物标志物捕获了3000多个测量值。这些广泛的数据允许用户观察他们的生活方式决定对健康的直接和长期影响，首次提供了他们激素水平自然昼夜节律的详细视图。。

Corti's real-time insights offer a new dimension in understanding personal health, sleep analysis, and stress management. Users can uncover what triggers stress hormone spikes, see how melatonin levels align with their sleep readiness, and learn how diet, exercise, and other lifestyle choices impact these short-term and chronic stress levels.

Corti的实时见解为理解个人健康、睡眠分析和压力管理提供了一个新的维度。用户可以发现是什么触发了压力激素的峰值，了解褪黑激素水平如何与他们的睡眠准备相一致，并了解饮食，运动和其他生活方式选择如何影响这些短期和慢性压力水平。

By comfortably tracking these changes throughout the day and night, Corti sheds light on how activities affect base hormone levels and circadian rhythms, providing a deeper understanding of aging health and wellness impacts. This empowers users to make informed decisions for a healthier life, tailored to their body's unique personal responses..

通过昼夜舒适地跟踪这些变化，Corti揭示了活动如何影响基础激素水平和昼夜节律，从而更深入地了解衰老对健康和身心健康的影响。这使用户能够根据自己身体独特的个人反应，为更健康的生活做出明智的决定。。

'Corti represents the latest evolution of our advanced passive-sweat sensor technology, underpinned by rigorous clinical validation,' says Dr. Shalini Prasad, PhD, Professor and Department Head of Bioengineering at the University of Texas at Dallas and Co-founder of EnLiSense. 'Building on our extensive inflammatory biomarker research, we are actively conducting additional clinical studies that further validate cortisol and melatonin monitoring into our technology, providing a non-intrusive way to proactively keep an eye on our health,' Dr.

德克萨斯大学达拉斯分校（University of Texas at Dallas）教授兼生物工程系主任、EnLiSense联合创始人沙利尼·普拉萨德（Shalini Prasad）博士说：“Corti代表了我们先进的被动汗液传感器技术的最新发展，并得到了严格的临床验证。”在我们广泛的炎症生物标志物研究的基础上，我们正在积极进行额外的临床研究，进一步验证皮质醇和褪黑激素监测到我们的技术，提供一种非侵入性的方式来主动关注我们的健康。

Prasad adds. EnLiSense’s underlying technology boasts over a decade of research resulting in over 30 publications, with over 500,000 biomarker readings recorded in recent years demonstrating the technology’s robustness..

普拉萨德补充道。EnLiSense的基础技术拥有十多年的研究成果，发表了30多篇出版物，近年来记录的生物标志物读数超过500000，证明了该技术的稳健性。。

Throughout 2024, Corti will continue to introduce a range of sophisticated functionalities for its Corti users, including advanced analytics dashboards and unique AI models, designed to enhance users' understanding of the dynamics of their stress and sleep hormones. This suite will provide users with unprecedented benchmarking data and insights, and include an integrated journaling feature allowing users to connect their daily routines—such as diet, exercise, and sleep patterns—to hormonal variations seen in their data.

整个2024年，Corti将继续为其Corti用户引入一系列复杂的功能，包括高级分析仪表盘和独特的AI模型，旨在增强用户对压力和睡眠激素动态的理解。该套件将为用户提供前所未有的基准数据和见解，并包括一个集成的日志功能，允许用户将日常生活（如饮食，运动和睡眠模式）与数据中看到的激素变化联系起来。

This holistic approach not only deepens users' understanding of their physiological responses to various stressors and activities but also is the first step to a new era in personalized health and wellness monitoring..

这种整体方法不仅加深了用户对各种压力源和活动的生理反应的理解，而且是个性化健康监测新时代的第一步。。

For those eager to be part of this health revolution, EnLiSense has opened an active waitlist for those interested in the Corti launch, aiming to improve stress management and sleep quality. Moreover, we are actively working with partnering businesses to discover new applications, enhancing its integration into various health and wellness ecosystems..

对于那些渴望参与这场健康革命的人，EnLiSense为那些对Corti发布感兴趣的人开放了一个积极的候补名单，旨在改善压力管理和睡眠质量。此外，我们正在积极与合作企业合作，发现新的应用程序，加强其与各种健康和健康生态系统的整合。。

About EnLiSense CCM

关于EnLiSense CCM

EnLiSense stands at the forefront of medical innovation, spearheading the development of advanced sweat sensor technology for real-time, non-invasive monitoring. Their offerings include both a first-of-its-kind device and an advanced data and AI platform, blending cutting-edge hardware with sophisticated analytics.

EnLiSense站在医学创新的最前沿，率先开发用于实时、无创监测的先进汗液传感器技术。他们提供的产品包括同类设备中的首创设备和先进的数据和人工智能平台，将尖端硬件与复杂的分析相结合。

Their flagship products, IBD Aware and Corti, are not just wearables; they are gateways to a new era in personalized healthcare. These devices cater to a wide range of use cases, profoundly resonating with both clinicians and patients. They facilitate proactive chronic disease management in conditions like inflammatory bowel disease (IBD) and stress-related disorders, offering clinicians and patients unprecedented insights into both physiological and disease states for treatment timing and effectiveness, symptom management, and dietary and lifestyle adjustments – aspects previously inaccessible in real-time.

他们的旗舰产品IBD Aware和Corti不仅仅是可穿戴设备；他们是通往个性化医疗新时代的大门。这些设备迎合了广泛的用例，与临床医生和患者产生了深刻的共鸣。它们有助于在炎症性肠病（IBD）和压力相关疾病等疾病中积极主动地进行慢性疾病管理，为临床医生和患者提供前所未有的生理和疾病状态的见解，以了解治疗时机和有效性，症状管理以及饮食和生活方式调整-这些方面以前无法实时获得。

The technology is validated to continuously monitor a comprehensive range of biomarkers including Calprotectin, CRP, TNF-Alpha, IL-6, Cortisol, Melatonin, Glucose, and many others, transforming how healthcare professionals and patients approach treatment and management..

该技术经过验证，可连续监测钙卫蛋白，CRP，TNF-α，IL-6，皮质醇，褪黑激素，葡萄糖等多种生物标志物，从而改变医疗保健专业人员和患者的治疗和管理方式。。

The journey of EnLiSense CCM is characterized by a relentless pursuit of elevating the standard of care through continuous innovation. Their solutions are designed not only to meet current healthcare challenges but also to anticipate future needs. EnLiSense continues to expand research and development efforts into new biomarkers and disease applications, broadening the scope of the technology platform to encompass a wider spectrum of chronic conditions.

EnLiSense CCM的历程是通过不断创新不断提高护理标准。他们的解决方案不仅旨在应对当前的医疗挑战，而且还可以预测未来的需求。EnLiSense继续将研究和开发工作扩展到新的生物标志物和疾病应用，扩大了技术平台的范围，以涵盖更广泛的慢性病。

This expansion is underpinned by a commitment to cost-effective, precision medicine, ensuring that each advancement brings us closer to a future where healthcare is more personalized, proactive, and patient-centered..

这一扩张的基础是对具有成本效益的精准医学的承诺，确保每一项进步都使我们更接近未来，在未来，医疗保健更加个性化、主动和以患者为中心。。